Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
The requirements for new technologies to serve as anticancer agents go far beyond their toxicity potential. Novel applications also need to be safe on a molecular and patient level. In a broader sense, this also relates to cancer metastasis and inflammation. In a previous study, the toxicity of an a...
Main Authors: | Eric Freund, Chiara Spadola, Anke Schmidt, Angela Privat-Maldonado, Annemie Bogaerts, Thomas von Woedtke, Klaus-Dieter Weltmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, André Käding, Sander Bekeschus |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Physics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphy.2020.569618/full |
Similar Items
-
Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition
by: Sybille Hasse, et al.
Published: (2020-09-01) -
Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells
by: Aydar Khabipov, et al.
Published: (2021-05-01) -
Plasma-Derived Reactive Species Shape a Differentiation Profile in Human Monocytes
by: Eric Freund, et al.
Published: (2019-06-01) -
Activation of Murine Immune Cells upon Co-culture with Plasma-treated B16F10 Melanoma Cells
by: Katrin Rödder, et al.
Published: (2019-02-01) -
Physical Plasma-Treated Skin Cancer Cells Amplify Tumor Cytotoxicity of Human Natural Killer (NK) Cells
by: Ramona Clemen, et al.
Published: (2020-11-01)